PK Study to Assess Drug-drug Interaction Between Sitravatinib and a P-gp Inducer and an Inhibitor.
Clinical trial NCT05255276 · COMPLETED
Trial details
- NCT number
- NCT05255276
- Sponsor
- Mirati Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-02
- Primary completion
- 2022-05-12
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.